Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : ABX-01
Therapeutic Area : Infections and Infectious Diseases
Study Phase : IND Enabling
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Centauri Picks First Clinical Candidate for Gram-Negative Bacterial Infections
Details : ABX-01 is an immunotherapeutic drug candidate, which is currently being evaluated for the patients suffering with gram-negative bacterial lung infections.
Product Name : Undisclosed
Product Type : Peptide-drug Conjugate
Upfront Cash : Inapplicable
March 04, 2025
Lead Product(s) : ABX-01
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : IND Enabling
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
